Stock Information
BridgeBio Pharma Inc (BBIO)
Ticker Symbol: BBIO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $14,096.65 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.7841
Revenue (TTM): $2.59 M
Dividend Yield: N/A%
ROE: -206.74%
Latest News
-
BridgeBio Pharma Inc (NASDAQ:BBIO) Shows High Technical and Setup Ratings Ahead of Potential Breakout
Sat, Apr 11, 2026 11:01 AM
-
CANC: I Give A Hold Rating To This ETF That Invests In Cancer-Fighting Stocks
Fri, Apr 10, 2026 8:00 AM
-
RBC Capital Initiates Coverage On BridgeBio Pharma with Outperform Rating, Announces Price Target of $100
Thu, Apr 9, 2026 11:20 AM
Key Financials
Financial data not available
